OFM
Omega Fund Management Portfolio holdings
AUM
$154M
This Quarter Return
+3.07%
1 Year Return
-32.78%
3 Year Return
+82.35%
5 Year Return
+29.08%
10 Year Return
+90.46%
AUM
$392M
AUM Growth
+$392M
(+26%)
Cap. Flow
+$83M
Cap. Flow
% of AUM
21.17%
Top 10 Holdings %
Top 10 Hldgs %
96.93%
Holding
17
New
4
Increased
–
Reduced
1
Closed
2
Top Buys
| 1 |
MORF
Morphic Holding, Inc. Common Stock
MORF
|
$58.9M |
| 2 |
Immunic
IMUX
|
$15.7M |
| 3 |
Trevi Therapeutics
TRVI
|
$9.48M |
| 4 |
PRVL
Prevail Therapeutics Inc. Common Stock
PRVL
|
$8.83M |
Top Sells
| 1 |
CBAY
Cymabay Therapeutics
CBAY
|
$7.32M |
| 2 |
DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
|
$2.45M |
| 3 |
PVLA
Palvella Therapeutics, Inc. Common Stock
PVLA
|
$112K |
Sector Composition
| 1 | Healthcare | 100% |
